\
&
Contact us
\
&
Contact us
Starts in 3 weeks from now
Locationwebinar
ProgrammesThe Commission will give details about:
A Q&A session with SLIDO is foreseen.
The programme and the link to the You Tube live stream can be found on this link. No prior registration is requested.
You can also go directly to the Commission You Tube channel: EU Science & Innovation - YouTube (tab live).
Details about grant management (reporting and payments) will be explained in a webinar by the Commission on 3 April (cfr. our event calendar). On 13 March a webinar on funding opportunities and submitting a proposal is also scheduled (cfr. our event calendar).
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Security Digital, Industry & Space Digital Europe Cybersecurity Defence
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
